These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19169217)

  • 41. Cutaneous invasive squamous cell carcinoma: 10-year experience and recommendations for follow up.
    Yoong C; De'Ambrosis B
    Australas J Dermatol; 2009 Nov; 50(4):261-5. PubMed ID: 19916969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Epidemiology of chronic UV-damage].
    Diepgen TL
    J Dtsch Dermatol Ges; 2005 Sep; 3 Suppl 2():S32-5. PubMed ID: 16117742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Squamous cell carcinomas in children and young adults: a new wave of a very rare tumor?
    Chow CW; Tabrizi SN; Tiedemann K; Waters KD
    J Pediatr Surg; 2007 Dec; 42(12):2035-9. PubMed ID: 18082703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system.
    Brougham ND; Tan ST
    J Surg Oncol; 2014 Dec; 110(7):876-82. PubMed ID: 25088537
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics and Trends of Cutaneous Squamous Cell Carcinoma in a Patient Cohort in Finland 2006-2015.
    Korhonen N; Ylitalo L; Luukkaala T; Itkonen J; Häihälä H; Jernman J; Snellman E; Palve J
    Acta Derm Venereol; 2019 Apr; 99(4):412-416. PubMed ID: 30628632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histopathology of cutaneous squamous cell carcinoma.
    Maguire B; Smith NP
    Clin Dermatol; 1995; 13(6):559-68. PubMed ID: 8882767
    [No Abstract]   [Full Text] [Related]  

  • 47. Most cases of cutaneous squamous cell carcinoma in Japan are classified as "high risk" according to the Japanese guideline.
    Umebayashi Y; Akama T; Manabe M
    J Dermatol; 2012 Sep; 39(9):812-4. PubMed ID: 22168529
    [No Abstract]   [Full Text] [Related]  

  • 48. Risk factors for recurrent and metastatic cutaneous squamous cell carcinoma in immunocompromised patients.
    Dong J; Lee T; Desman GT; Ratner D
    J Am Acad Dermatol; 2020 Nov; 83(5):1473-1475. PubMed ID: 32199888
    [No Abstract]   [Full Text] [Related]  

  • 49. Multiple Cutaneous Squamous Cell Carcinoma in Immunosuppressed vs Immunocompetent Patients.
    Gonzalez JL; Reddy ND; Cunningham K; Silverman R; Madan E; Nguyen BM
    JAMA Dermatol; 2019 May; 155(5):625-627. PubMed ID: 30865240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cutaneous lichen planus and squamous cell carcinoma.
    Patel GK; Turner RJ; Marks R
    J Eur Acad Dermatol Venereol; 2003 Jan; 17(1):98-100. PubMed ID: 12602985
    [No Abstract]   [Full Text] [Related]  

  • 51. Staging cutaneous squamous cell carcinoma in an Irish cohort.
    Doyle C; Drumm C; Hellen R; McKay H; D'Arcy C; Lally A; Moriarty B
    Clin Exp Dermatol; 2023 Mar; 48(4):405-406. PubMed ID: 36715350
    [No Abstract]   [Full Text] [Related]  

  • 52. Animal model of human disease. Squamous cell carcinoma. Ovine squamous cell carcinoma.
    Ladds PW; Daniels PW
    Am J Pathol; 1982 Apr; 107(1):122-3. PubMed ID: 7065122
    [No Abstract]   [Full Text] [Related]  

  • 53. Prospective study evaluating the personal history of rosacea and risk of cutaneous squamous cell carcinoma among women in the United States.
    Lin EM; Rajadurai S; Qureshi AA; Cho E
    J Am Acad Dermatol; 2022 Dec; 87(6):1389-1391. PubMed ID: 36089188
    [No Abstract]   [Full Text] [Related]  

  • 54. Genetically Predicted Serum Vitamin C Levels and Cutaneous Squamous Cell Carcinoma Risk.
    Kim Y; Yin J; Le Breton S; Jorgenson E; Huang H; Choquet H; Asgari MM
    J Invest Dermatol; 2023 Apr; 143(4):664-667. PubMed ID: 36343677
    [No Abstract]   [Full Text] [Related]  

  • 55. Cutaneous squamous cell carcinoma: a smoking gun but still no suspects.
    Schiller JT; Buck CB
    J Invest Dermatol; 2011 Aug; 131(8):1595-6. PubMed ID: 21753763
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Incidence and Risk Factors for De Novo Cutaneous Squamous Cell Carcinoma in a Contemporary Cohort of Long-Term Hematopoietic Cell Transplantation Survivors.
    Berano Teh J; Abdulla F; Peng K; Atencio L; Echevarria M; Iukuridze A; Geller AC; Wong FL; Forman SJ; Nakamura R; Modi B; Armenian SH
    J Invest Dermatol; 2021 Aug; 141(8):2073-2076.e5. PubMed ID: 33609555
    [No Abstract]   [Full Text] [Related]  

  • 57. [Skin metastases seen at the pathology laboratory in Lome, Togo, between 2005 and 2014].
    Darre T; Saka B; Landoh DE; Mouhari-Toure A; Amegbor K; Pitché P; Napo-Koura G
    Pan Afr Med J; 2015; 22():388. PubMed ID: 27047627
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comment on: the incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system.
    Jambusaria-Pahlajani A; Karia PS; Parker AS; Schmults CD
    J Surg Oncol; 2015 Mar; 111(4):483-4. PubMed ID: 25492622
    [No Abstract]   [Full Text] [Related]  

  • 59. Reply to comment on: the incidence and risk factors of metastasis for cutaneous squamous cell carcinoma--implications on the T-classification system.
    Brougham ND; Tan ST
    J Surg Oncol; 2015 Mar; 111(4):485-6. PubMed ID: 25492800
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunosuppression and skin cancer: pathogenetic insights, therapeutic challenges, and opportunities for innovation.
    Otley CC
    Arch Dermatol; 2002 Jun; 138(6):827-8. PubMed ID: 12056967
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.